DraftKings, Sage Therapeutics, Vroom and extra

New England Patriots cornerback Stephon Gilmore (24) stretches through the New England Patriots follow session in Foxborough, MA on Oct. 22, 2020.

Barry Chin | Boston Globe | Getty Photographs

Sage Therapeutics — Shares of the drug maker fell about 17% after the launch of research outcomes for its experimental melancholy drug. The remedy resulted in a statistically important enchancment in signs, though it might take as much as six weeks to be efficient.

Vroom —  The used-vehicle e-commerce platform supplier’s shares fell greater than 10% after it introduced a convertible be aware providing of $500 million in convertible senior notes due 2026. Vroom plans to make use of the proceeds to spend money on new applied sciences and different company functions.

Novavax — Shares of Novavax fell over 7% regardless of the biotech agency’s announcement Monday that its Covid-19 vaccine is secure and 90.4% efficient. The corporate additionally stated its vaccine stays efficient when co-administered with the flu shot.

Ping Identification — The identification administration options firm noticed its shares fall greater than 8% after asserting it will supply 6 million shares of frequent inventory by funding funds affiliated with Vista Fairness Companions. Ping stated it won’t obtain any proceeds from the sale however will bear the prices related to it.

DraftKings — The sports activities betting firm shed greater than 5% after Hindenburg Analysis revealed that it had a brief place in opposition to the inventory. Hindenburg’s report highlighted DraftKing’s valuation as a priority and alleged involvement in questionable playing exercise by SBTech, which DraftKings merged with in 2020. DraftKings stated in an announcement that it was comfy with SBTech’s enterprise historical past.

Fastenal — Shares of the maker of business and constructions provides dropped greater than 1% following a downgrade at Morgan Stanley. The financial institution slashed its ranking on Fastenal to underweight from equal weight, saying the inventory had restricted upside as a result of a excessive valuation and execution threat because it continues the transition.

MicroStrategy — MicroStrategy’s shares rose 2.9% after it stated late Monday it plans to plans to promote as much as $1 billion in inventory to purchase extra bitcoin. The enterprise software program firm presently owns greater than 92,000 bitcoins. Bitcoin’s value can also be recovering this week from its value declines of the final month.

Exxon Mobil — Shares of the oil large superior 2.9% on the heels of an uptick within the value of oil, and after Financial institution of America reiterated its purchase ranking on the inventory. The agency believes Exxon will increase its dividend earlier than the tip of the 12 months, and sees shares leaping 45% from their Monday closing value to $90.

 — CNBC’s Maggie Fitzgerald, Hannah Miao, Jesse Pound, Yun Li and Pippa Stevens contributed reporting

Turn out to be a wiser investor with CNBC Professional
Get inventory picks, analyst calls, unique interviews and entry to CNBC TV. 
Signal as much as begin a free trial at present

Supply hyperlink

Leave a Reply

Your email address will not be published. Required fields are marked *

Leave a comment
scroll to top